Potato chip recall upgraded to highest FDA risk level over salmonella concerns
The FDA has upgraded a potato chip recall involving brands like Utz Zapp's and Dirty to Class I, its highest risk level, due to salmonella concerns.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The FDA has reclassified a recall of popular potato chips to Class I, the agency's highest risk level. This action follows concerns that the products may be contaminated with salmonella.
Coverage from The Guardian, Yahoo, USA Today and ABC7 Los Angeles emphasizes the severity of the upgrade. Outlets such as WGAL and AL.com specifically note the risk level increase, while Yahoo identifies Utz Zapp's and Dirty chips as affected brands.
Future developments depend on further updates regarding the contamination and the scope of the recall from the FDA and the snack company involved.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 2h ago.
Quick answers
Which brands are affected by the recall?
According to Yahoo, the recall involves Utz Zapp's and Dirty chips.
What is the reason for the recall upgrade?
The recall was upgraded to the highest risk level due to salmonella concerns.
What FDA risk level has been assigned to this recall?
The FDA has classified the recall as Class I.
Coverage (16)
- FDA reclassifies major potato chip recall to highest level KY3 · 3h ago
- FDA reclassifies major potato chip recall to highest level WMTV 15 NEWS · 3h ago
- Utz Potato Chip Recall Receives FDA’s Highest Risk Level Due to Possible Salmonella Contamination TODAY.com · 3h ago
- FDA upgrades potato chip recall to Class I over salmonella risk WESH · 4h ago
- Potato chip recall elevated to FDA’s highest risk level FOX21 News Colorado · 4h ago
- Potato chips recalled over salmonella fears. Where they were sold Detroit Free Press · 4h ago
- FDA upgrades Utz Zapp's and Dirty chip recall to Class I Yahoo · 4h ago
- Recall of popular potato chips upgraded to highest FDA risk over salmonella fears AL.com · 4h ago
- FDA issues most serious recall alert for potato chip brands over salmonella risk The Guardian · 4h ago
- Popular chip recall now highest FDA risk FOX 8 News · 4h ago
- Recall of popular potato chips classified under FDA's highest risk level Yahoo · 17h ago
- Popular chips given highest risk level over salmonella concerns MySA · 1d ago
- Potato chips recalled by massive snack company, potentially contaminated with salmonella WKRC · 1d ago
- Recall of popular potato chips classified under FDA's highest risk level USA Today · 1d ago
- FDA upgrades potato chip recall to Class I over salmonella risk WGAL · 1d ago
- Potato chip recall upgraded to highest FDA risk level over salmonella concerns ABC7 Los Angeles · 1d ago broke it first
People, places & organizations
Topics
Related trends
Exclusive: FDA allows ZYN to sell pouches on health benefits
The FDA has granted Philip Morris permission to market ZYN nicotine pouches as a safer, lower-risk alternative to cigarettes.
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
The FDA has launched a new initiative to accelerate the review process for new pharmaceutical manufacturing facilities.
Supplements sold online through major retailers recalled nationwide over potential salmonella risk
Major online retailers are recalling TNVitamins moringa powder supplements nationwide due to potential salmonella contamination.
Nearly 1 million bottles of heart and kidney medication recalled over foreign substance found on tablets
Nearly 1 million bottles of heart and kidney medications have been recalled nationwide due to the discovery of foreign substances on the tablets.
Potato chip recall upgraded to highest FDA risk level over salmonella concerns
The FDA has classified a massive recall of Utz potato chip brands as a Class I risk due to potential salmonella contamination.
New Drugs Are Replacing Chemo for Aggressive Breast Cancer
The FDA has granted broad first-line approval for Gilead's Trodelvy, signaling a shift away from traditional chemotherapy for aggressive breast cancer.